uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 04, 2014

Smoking Cessation and Anti-Inflammatory Supplements Contain Unapproved Ingredient

On December 13, 2013, the FDA issued a warning letter to Star Scientific, Inc. after the agency noted that the company's smoking cessation supplement CigRx and anti-inflammatory supplement Anatabloc contain anatabine, a chemical not currently allowed in dietary supplements. Statements made about Anatabloc were also found to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at